Jonakayem Pharma Formulation (OPC) Pvt. Ltd.
OCTREOTIDE

OCTREOTIDE

Send Inquiry
Product: OCTREOTIDE
Formulary: Generic Formulary
Category: Endocrine System
Sub Group: GROWTH DISORDER
International Brand Name: Sandostatin
Dosages: 50 MCG/100MG
Unit of Packing: Amp
In treatment of: Mgt of secretory neoplasms;treatment of acromegaly,prevention of complications following pancreatic surgery

Adverse Effects: 

  • Nausea 
  • Abdominal pain 
  • Dirrhoea 
  • Steatorrhoea 
  • Acute pancreatitis. 
  • Flushing 
  • Gall stones 
  • Pin and irritation at injection site 
  • Altered glucose tolerance 
  • Hepatic dysfunction

Contraiindication: Hypersensitivity to the drug or it`s components.

Special Precaution: 

  • Diabetes mellitus 
  • Monitor thyroid function on prolonged therapy 
  • Perform ultrasonic examination of gall bladder before and periodically during the therapy 
  • Renal impairment 
  • The drug should be gradually withdrawn.

Interaction: May alter the absorption of dietary fats. Depressed Vitamin B12 levels and abnormal Schilling`s test have been observed. Cyclosporin : May reduce the efficacy of cyclosporins.

Servings: S.C.: Starts with 50 to 100mcg once or twice daily. Gradually increased to 200 to 500mcg three times daily depending up on the patient`s response. Acromegaly, short term treatment prior to pituitary surgery: 100 to 200mcg thrice daily I.V.: Carcinoid crisis: 50mcg diluted with saline and given as bolus.